Llinks, Freshfields advise drugmaker Henlius on $410 mln Hong Kong IPO
BY Hu Yangxiaoxiao 胡阳潇潇 |
Llinks Law Offices and Freshfields Bruckhaus Deringer have represented Shanghai Henlius Biotech on its $410 million Hong Kong initial public offering, with Jia Yuan Law Offices and Sidley Austin advising the sponsors.